Grown Rogue International (GRUSF) Share-based Compensation (2011 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Share-based Compensation of $154994.0 in Q1 2026, up 100.0% quarter-over-quarter from -$1969.7 billion in Q4 2025, and down 89.21% on a YoY basis from $1.4 million in Q1 2025.
Grown Rogue International (GRUSF) Share-based Compensation (2011 - 2026) Analysis & Trends
Grown Rogue International's Share-based Compensation history runs 15 years deep, the most recent figure standing at $154994.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 89.21% year-over-year to $154994.0; the TTM figure through Mar 2026 stood at -$157635.0 (down 105.27% YoY), while the FY2025 annual figure was $1.1 million, down 14.03% from the prior year.
- Share-based Compensation was $154994.0 for Q1 2026 at Grown Rogue International, up from -$1969.7 billion in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1969.7 billion in Q3 2025 to a low of -$1969.7 billion in Q4 2025.
- Historically, Share-based Compensation has averaged $235349.8 across 5 years, with a median of $55622.0 in 2023.
- Biggest YoY gain for Share-based Compensation was 2455.68% in 2025; the steepest drop was 419.48% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $13765.0 in 2022, then jumped by 594.25% to $95563.0 in 2023, then sank by 396781690.34% to -$379.2 billion in 2024, then plunged by 419.48% to -$1969.7 billion in 2025, then surged by 100.0% to $154994.0 in 2026.
- The last three Share-based Compensation figures came in at $154994.0 (Q1 2026), -$1969.7 billion (Q4 2025), and $1969.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 154,994.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154,994.00 |
| Mar 31, 2026 | 154,994.00 |
| Dec 31, 2025 | -1,969.73 Bn |
| Dec 31, 2025 | -1,969.73 Bn |
| Sep 30, 2025 | 1,969.73 Bn |
| Sep 30, 2025 | 1,969.73 Bn |
| Jun 30, 2025 | 6,433.00 |
| Jun 30, 2025 | 6,433.00 |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | -379.18 Bn |
| Dec 31, 2024 | -379.18 Bn |
| Sep 30, 2024 | 379.18 Bn |
| Sep 30, 2024 | 379.18 Bn |
| Jun 30, 2024 | 28,186.00 |
| Jun 30, 2024 | 28,186.00 |
| Mar 31, 2024 | 56,185.00 |
| Mar 31, 2024 | 56,185.00 |
| Apr 30, 2023 | 95,563.00 |
| Apr 30, 2023 | 95,563.00 |